| 发明名称 |
PREDICTING RISK OF MAJOR ADVERSE CARDIAC EVENTS |
| 摘要 |
Measurement of circulating ST2 and natriuretic peptide (e.g., NT-proBNP) concentrations is useful for the prognostic evaluation of subjects, in particular for the prediction of adverse clinical outcomes, e.g., mortality, transplantation, and heart failure. |
| 申请公布号 |
HK1152750(A1) |
申请公布日期 |
2014.05.02 |
| 申请号 |
HK20110106781 |
申请日期 |
2011.07.04 |
| 申请人 |
CRITICAL CARE DIAGNOSTICS INC. |
发明人 |
SNIDER, JAMES, V.;HEYMAN, EUGENE, R. |
| 分类号 |
G01N;C12Q |
主分类号 |
G01N |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
